Jaguar Health’s Posts Crofelemer Data For Chemo-Induced Diarrhea In Breast Cancer Patients
Jaguar Health Inc (NASDAQ: JAGX)
Jaguar Health Announces Topline Results Of Investigator-Initiated Phase 2 Study Of Crofelemer
Jaguar Health, Inc. (NASDAQ:JAGX) today announced topline results of the third-party, investigator-initiated Phase 2 HALT-D trial evaluating crofelemer for the prevention of chemotherapy-induced diarrhea (CID) in
Earnings Scheduled For November 17, 2021
Companies Reporting Before The Bell
• ZIM Integrated Shipping (NYSE:ZIM) is projected to report quarterly earnings at $9.25 per share on revenue of $2.77 billion.
Jaguar Health Shares See Light Volume Following Press Release Highlighting Closing Of Deal Between Its Italian Subsidiary, Napo EU And Dragon SPAC; BZ NOTE: The Italian Gov’t. Cleared The Deal On Oct. 25
Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the merger of its Italian subsidiary Napo EU S.p.A. and Dragon SPAC S.p.A. has closed.
"We know shareholders and other stakeholders have been eagerly awaiting
44 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI) shares climbed 105.3% to $4.4350. AgriFORCE Growing Systems reported binding LOI to acquire a European agriculture/horticulture and agtech consulting firm for $29 million.
61 Biggest Movers From Yesterday
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the development 1,040 ART systems in Spain and Portugal.